Posted in | News | Imaging

Tianma NLT America Launches New 21.3" Diagonal QXGA LCD Prototype with SFT2 and Quantum Dot Technology

Leading LCD supplier Tianma NLT America is introducing a new 21.3" diagonal QXGA (Quad Extended Graphics Array) LCD prototype that features quantum dot technology with NLT Technologies' proprietary new SFT2 (Super Fine TFT2) technology.

SFT2 is NLT's proprietary new version of SFT, comparable to In-Plane Switching, and a technology that provides excellent viewing performance, even in extreme, off-angle viewing conditions. It significantly improves the aperture ratio compared to conventional TFT via a newly developed pixel structure, resulting in high transmissivity and wide viewing angles. Thanks to the ultra-high aperture ratio, the light transmissivity dramatically increases, enabling a significant reduction in backlight power consumption (reduced approximately 30% compared with conventional LCDs).

In addition to SFT2, the prototype also utilizes quantum dot technology. This technology adjusts the wavelength of incident light and enriches color gamut. Usually, adaption of quantum dot technology reduces the luminance of the backlight, causing higher power consumption. When combined with SFT2, however, rich colors can be displayed at high brightness with low power consumption.

The display achieves high luminance (700 cd/m2), high resolution and 100% Adobe RGB coverage. The combination of SFT2 and quantum dot technology results in better image quality with deeper color saturation, especially superior red color reproduction, making it ideal for medical diagnostic applications as well as graphics and broadcast applications.

A prototype of the new QXGA/quantum dot LCD with SFT2 technology will be showcased at Display Week 2015 in San Jose, California, June 2-4, in Booth 917.

For more information, contact Tianma NLT America, Inc., 2801 Scott Blvd., Santa Clara, CA 95050. 1-408-816-7010; [email protected]; www.tianma-nlt.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.